Clinical Trial Update: Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver Tumors

View source ↗

Summary

A pediatric trial evaluating Yttrium-90 radioembolization for liver tumors has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatoblastoma
• Hepatocellular Carcinoma
• Rhabdoid Tumor of the Liver
• Undifferentiated Embryonal Sarcoma of the Liver

Drugs mentioned

• Yttrium-90 radioembolization (yttrium-90 microspheres)

Snippet

Sponsor: Nemours Children's Clinic | Conditions: Hepatoblastoma, Hepatocellular Carcinoma | Status: TERMINATED